Christopher P. Denton

Active 1995–2025

Also published as
Christopher P Denton
302
Papers
50,576
Citations
114
h-index
282
i10-index

Citations

Citations per year for Christopher P. Denton1982: 6 citations1985: 1 citations1986: 1 citations1996: 2 citations1997: 1 citations1998: 7 citations1999: 4 citations2000: 3 citations2001: 5 citations2002: 14 citations2003: 24 citations2004: 45 citations2005: 57 citations2006: 103 citations2007: 141 citations2008: 168 citations2009: 180 citations2010: 280 citations2011: 258 citations2012: 255 citations2013: 282 citations2014: 311 citations2015: 303 citations2016: 336 citations2017: 394 citations2018: 356 citations2019: 1,707 citations2020: 2,020 citations2021: 2,077 citations2022: 1,750 citations2023: 1,190 citations2024: 1,851 citations2025: 937 citations2026: 20 citations1983–1984: no citations, so these years are not shown1987–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,098 citing papers, 21.4% of this breakdownUnited Kingdom: 1,308 citing papers, 9.1% of this breakdownItaly: 1,087 citing papers, 7.5% of this breakdownChina: 1,015 citing papers, 7% of this breakdownGermany: 921 citing papers, 6.4% of this breakdownFrance: 902 citing papers, 6.2% of this breakdownCanada: 598 citing papers, 4.1% of this breakdownNetherlands: 505 citing papers, 3.5% of this breakdownJapan: 493 citing papers, 3.4% of this breakdownSwitzerland: 477 citing papers, 3.3% of this breakdownSpain: 371 citing papers, 2.6% of this breakdownAustralia: 322 citing papers, 2.2% of this breakdown
0%21.4%Other 23.3%

Fields

  • Medicine81.9%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Immunology and Microbiology3.1%
  • Neuroscience0.7%
  • Engineering0.5%
  • Materials Science0.2%
  • Other1.2%

Topics

  • Systemic Sclerosis and Related Diseases13.3%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.5%
  • Pulmonary Hypertension Research and Treatments8.2%
  • Inflammatory Myopathies and Dermatomyositis4.3%
  • Connective Tissue Growth Factor Research1.8%
  • Dermatologic Treatments and Research1.8%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

    Authors: , , , , , , , - European Respiratory Journal 2018 cited by 3,806

  2. Systemic sclerosis

    Authors: , - The Lancet 2017 cited by 2,155

  3. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 cited by 3,406

  4. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 cited by 652

  5. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Szucs, Carlos Alberto von Mühlen, Valeria Riccieri, Srđan Novak, Carlo Chizzolini, Anna Kotulska, Christopher P. Denton, Paulo C Coelho, Ina Kötter, İsmail Şimşek, Paloma García de la Peña Lefebvre, É. Hachulla, James R. Seibold, Simona Rednic, Jiří Štork, Jadranka Morović‐Vergles, Ulrich A. Walker - Annals of the Rheumatic Diseases 2010 cited by 1,428

  6. Interstitial Lung Disease in Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2008 cited by 1,193

  7. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arvind Rajasekaran, Lisa Spencer, Vicky Tsipouri, Zhe Wu, Georgio Xydopoulos, Fernando Zanghelini - The Lancet Respiratory Medicine 2022 cited by 271

  8. Systemic sclerosis

    Authors: , , , , , , - Nature Reviews Disease Primers 2015 cited by 862

  9. State-of-the-art evidence in the treatment of systemic sclerosis

    Authors: , , , , , - Nature Reviews Rheumatology 2023 cited by 191

  10. Update of EULAR recommendations for the treatment of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana and 35 more - Annals of the Rheumatic Diseases 2016 cited by 1,116

  11. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 669

  12. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 cited by 500

  13. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

    Authors: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 cited by 825

  14. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Journal of Scleroderma and Related Disorders 2017 cited by 521

  15. Definition, classification and diagnosis of pulmonary hypertension

    Authors: , , , , , , , - European Respiratory Journal 2024 cited by 371

  16. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Callejas-Rubio, José Antonio Vargas‐Hitos, Rosa García-Portales, M T Camps, Antonio Fernández‐Nebro, Marı́a-Francisca González-Escribano, Francisco José García Hernández, María Jesús Castillo, M. Á. Aguirre, Inmaculada Gómez-Gracia, Benjamín Fernández‐Gutiérrez, Luis Rodríguez‐Rodríguez, Paloma García de la Peña, Esther Vicente, José Luís Andreu, M. Fernández Castro, Francisco Javier López-Longo, Leticia Quintanilla Martinez, Fonollosa, Alberto Guillén, Gerard Espinosa, Carlos Tolosa, A. Pros, Mónica Rodríguez‐Carballeira, Javier Narváez, Manuel Rubio‐Rivas, Ortiz-Santamaría, Ana Belén Madroñero, Miguel Á. González‐Gay, Bianca J. Diaz, Luis Trapiella, André M. M. Sousa, M. V. Egurbide, P. Fanlo-Mateo, Luís Sáez-Comet, Fidel Díez Díaz, Hernández, E. Beltrán, José Andrés Román-Ivorra, Elena Grau, Juan José Alegre Sancho, M. Freire, Francisco J. Blanco, N. Oreiro, Torsten Witte, Alexander Kreuter, G. Riemekasten, Paolo Airó, C. Magro, Alexandre E. Voskuyl, M. C. Vonk, Roger Hesselstrand, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), Jane Zochling, J. Sahhar, Janet Roddy, Peter Nash, Kathleen Tymms, Maureen Rischmueller, Sue Lester, Timothy J. Vyse, Ariane L. Herrick, Jane Worthington, Christopher P. Denton, Yannick Allanore, Matthew A. Brown, Timothy R. D. J. Radstake and 4 more - Nature Communications 2019 cited by 188

  17. Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

    Authors: , , , , , , , - Arthritis & Rheumatology 2017 cited by 351

  18. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

    Authors: , , , , , , , , , , - Current Medical Research and Opinion 2019 cited by 258

  19. Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

    Authors: , , , , , , , - Arthritis & Rheumatology 2014 cited by 457

  20. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 364

  21. Predictors of progression in systemic sclerosis patients with interstitial lung disease

    Authors: , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 239

  22. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 212

  23. Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

    Authors: , , , , , , , - Arthritis & Rheumatology 2019 cited by 214

  24. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension

    Authors: , , , , , , - American Journal Of Pathology 2015 cited by 354